EMERGENT BIOSOLUTIONS INC. Effective Tax Rate
EMERGENT BIOSOLUTIONS INC. (EBS) reported Effective Tax Rate of -13.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 49.00%, a 81.48% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for the quarter ending 2025-03-31 was 27.00%, a 3.85% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was 26.00%.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was -16.00%.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for fiscal 2024 was -33.00%.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for fiscal 2023 was -4.00%, a 233.33% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for fiscal 2022 was 3.00%, a 89.29% decline from fiscal 2021.
- EMERGENT BIOSOLUTIONS INC. effective income tax rate reconciliation, percent for fiscal 2021 was 28.00%, a 7.69% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -13.00% 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 49.00% 10-Q · filed 2026-05-01 | ||||||
| 2025-12-31 | 26.00% 10-Q · filed 2026-08-06 | 36.50% 10-K · filed 2026-02-27 | |||||
| 2025-09-30 | 20.00% 10-Q · filed 2025-10-30 | ||||||
| 2025-06-30 | 26.00% 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 27.00% 10-Q · filed 2026-05-01 | ||||||
| 2024-12-31 | -33.00% 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | -38.00% 10-Q · filed 2025-10-30 | ||||||
| 2024-06-30 | -6.00% 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | 26.00% 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | -4.00% 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | -5.00% 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -9.00% 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | -16.00% 10-Q · filed 2024-05-02 | ||||||
| 2022-12-31 | 3.00% 10-K · filed 2025-03-04 | -1.00% 10-K · filed 2023-03-01 | |||||
| 2021-12-31 | 28.00% 10-K · filed 2024-03-08 | -27.00% 10-K · filed 2022-02-25 | |||||
| 2021-06-30 | 26.00% 10-Q · filed 2021-07-30 | 26.00% 10-Q · filed 2021-07-30 | |||||
| 2021-03-31 | 26.00% 10-Q · filed 2021-04-30 | ||||||
| 2020-12-31 | 26.00% 10-K/A · filed 2023-12-11 | 25.00% 10-K · filed 2021-02-19 | |||||
| 2020-09-30 | 29.00% 10-Q · filed 2020-11-06 | ||||||
| 2020-06-30 | 26.00% 10-Q · filed 2021-07-30 | 26.00% 10-Q · filed 2021-07-30 | |||||
| 2020-03-31 | 26.00% 10-Q · filed 2021-04-30 | ||||||
| 2019-12-31 | 30.00% 10-K · filed 2022-02-25 | ||||||
| 2019-09-30 | 27.00% 10-Q · filed 2020-11-06 | 26.00% 10-Q · filed 2019-11-07 | |||||
| 2019-06-30 | 27.00% 10-Q · filed 2020-07-31 | ||||||
| 2019-03-31 | 27.00% 10-Q · filed 2020-05-01 | ||||||
| 2018-12-31 | 23.00% 10-K · filed 2021-02-19 | ||||||
| 2018-09-30 | 26.00% 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | 25.00% 10-Q · filed 2019-08-02 | ||||||
| 2018-03-31 | 26.00% 10-Q · filed 2019-05-08 | 24.00% 10-Q · filed 2018-05-04 | |||||
| 2017-12-31 | 30.00% 10-K · filed 2020-02-25 | ||||||
| 2017-09-30 | 32.00% 10-Q · filed 2018-11-02 | ||||||
| 2017-06-30 | 31.00% 10-Q · filed 2018-08-03 | ||||||
| 2017-03-31 | 31.00% 10-Q · filed 2018-05-04 | ||||||
| 2016-12-31 | 37.00% 10-K · filed 2019-02-22 | ||||||
| 2016-09-30 | 37.00% 10-Q · filed 2016-11-09 | ||||||
| 2016-03-31 | 34.00% 10-Q · filed 2017-05-05 | ||||||
| 2015-12-31 | 33.00% 10-K · filed 2018-02-23 | 30.00% 10-K · filed 2016-02-29 | |||||
| 2015-09-30 | 29.00% 10-Q · filed 2016-11-09 | ||||||
| 2014-12-31 | 36.00% 10-K · filed 2017-02-28 | 31.00% 10-K · filed 2015-03-09 | |||||
| 2013-12-31 | 30.00% 10-K · filed 2016-02-29 | ||||||
| 2012-12-31 | 37.00% 10-K · filed 2015-03-09 | ||||||
| 2011-12-31 | 41.00% 10-K · filed 2014-03-10 | ||||||
| 2010-12-31 | 34.00% 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |